Medication use in children from the 2015 Pelotas (Brazil) birth cohort aged between three months and four years.


Journal

Cadernos de saude publica
ISSN: 1678-4464
Titre abrégé: Cad Saude Publica
Pays: Brazil
ID NLM: 8901573

Informations de publication

Date de publication:
2022
Historique:
received: 10 05 2021
accepted: 22 10 2021
entrez: 27 4 2022
pubmed: 28 4 2022
medline: 30 4 2022
Statut: epublish

Résumé

Medication use is an important part of the health process and prevalence of its use among infants can reach up to 65% in their first months of life. The excessive use of medication could lead to an increase in their potential harm, surpassing their benefits. Considering this, this study aimed to describe medication use in children aged 3, 12, 24, and 48 months. Standardized questionnaires were applied to assess patterns and covariables of medication use. Medication use was investigated as an outcome and defined as the receipt of any medication within 15 days before the interview. Prevalence of medication use and 95% confidence intervals (95%CI) were described using chi-squared tests. Prescription source and frequency of use were also reported, along with the most frequent medication in each follow-up. Medication use prevalence was 67.2% (95%CI: 65.8; 68.6), 68.2% (95%CI: 66.8; 69.6), 52.4% (95%CI: 50.9; 54.0), 47.2% (95%CI: 45.7; 48.8), at 3, 12, 24, and 48 months, respectively. We observed a decrease in the proportion of medically prescribed medications and an increase in self-medication over the years. Drugs for gastrointestinal disorders (A03), vitamins (A11), analgesics (N02), anti-inflammatories (M01), and nasal formulations (R01) were the most frequently used medications. We found that children under four years of age comprised over 50% of the total use of medications and self-medication. These results highlight the need to warn caregivers on the importance of proper professional examination and prescription before they administer medications to children.

Identifiants

pubmed: 35476048
pii: S0102-311X2022000305012
doi: 10.1590/0102311X00117221
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00117221

Auteurs

Simone Farías-Antúnez (S)

Universidade Federal de Pelotas, Pelotas, Brasil.

Marysabel Pinto Telis Silveira (MPT)

Universidade Federal de Pelotas, Pelotas, Brasil.

Marlos Rodrigues Domingues (MR)

Universidade Federal de Pelotas, Pelotas, Brasil.

Mariângela Freitas da Silveira (MFD)

Universidade Federal de Pelotas, Pelotas, Brasil.

Andréa Dâmaso Bertoldi (AD)

Universidade Federal de Pelotas, Pelotas, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH